Blog
Feedback
schliessen

Filtern

 

Bibliotheken

Logo der Bibliothek

Logo FID Pharmazie PubPharm Discovery System Universitätsbibliothek Braunschweig Institut für Informationssysteme

Treatments Administered to the First 9152 Reported Cases of COVID-19 : A Systematic Review

The emergence of SARS-CoV-2/2019 novel coronavirus (COVID-19) has created a global pandemic with no approved treatments or vaccines. Many treatments have already been administered to COVID-19 patients but have not been systematically evaluated. We performed a systematic literature review to identify all treatments reported to be administered to COVID-19 patients and to assess time to clinically meaningful response for treatments with sufficient data. We searched PubMed, BioRxiv, MedRxiv, and ChinaXiv for articles reporting treatments for COVID-19 patients published between 1 December 2019 and 27 March 2020. Data were analyzed descriptively. Of the 2706 articles identified, 155 studies met the inclusion criteria, comprising 9152 patients. The cohort was 45.4% female and 98.3% hospitalized, and mean (SD) age was 44.4 years (SD 21.0). The most frequently administered drug classes were antivirals, antibiotics, and corticosteroids, and of the 115 reported drugs, the most frequently administered was combination lopinavir/ritonavir, which was associated with a time to clinically meaningful response (complete symptom resolution or hospital discharge) of 11.7 (1.09) days. There were insufficient data to compare across treatments. Many treatments have been administered to the first 9152 reported cases of COVID-19. These data serve as the basis for an open-source registry of all reported treatments given to COVID-19 patients at www.CDCN.org/CORONA . Further work is needed to prioritize drugs for investigation in well-controlled clinical trials and treatment protocols

Year of Publication: 2020
Contained in: Infectious diseases and therapy Vol. 9, No. 3 (2020), p. 435-449
All journal articles: Search for all articles in this journal
Language: English
Contributors: Fajgenbaum, David C | Author
Khor, Johnson S
Gorzewski, Alexander
Tamakloe, Mark-Avery
Powers, Victoria
Kakkis, Joseph J
Repasky, Mileva
Taylor, Anne
Beschloss, Alexander
Hernandez-Miyares, Laura
Go, Beatrice
Nimgaonkar, Vivek
McCarthy, Madison S
Kim, Casey J
Pai, Ruth-Anne Langan
Frankl, Sarah
Angelides, Philip
Jiang, Joanna
Rasheed, Rozena
Napier, Erin
Mackay, Duncan
Pierson, Sheila K
Full text access:
Electronic availability is being checked...
Links: Full Text (dx.doi.org)
Keywords: COVID-19
Drug repurposing
Journal Article
Review
SARS-CoV-2
Systematic literature review
ISSN: 2193-8229
Note: Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Notes: Date Revised 22.09.2020
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PMID:
    32462545
Physical Description: Online-Ressource
ID (e.g. DOI, URN): 10.1007/s40121-020-00303-8
more publication details ...

Associated Publications

  • Associated records are being queried...
more (+)
Internes Format
LEADER 03824nma a2200721 c 4500
001 NLM311321232
003 DE-601
005 20200922213636.0
007 cr uuu---uuuuu
008 200528s2020 000 0 eng d
024 7 |a 10.1007/s40121-020-00303-8  |2 doi 
028 5 2 |a pubmed20n1347.xml 
035 |a (DE-599)NLM32462545 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 1 |a Fajgenbaum, David C 
245 1 0 |a Treatments Administered to the First 9152 Reported Cases of COVID-19  |h Elektronische Ressource  |b A Systematic Review 
300 |a Online-Ressource 
500 |a Date Revised 22.09.2020 
500 |a published: Print-Electronic 
500 |a Citation Status PubMed-not-MEDLINE 
500 |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine 
520 |a The emergence of SARS-CoV-2/2019 novel coronavirus (COVID-19) has created a global pandemic with no approved treatments or vaccines. Many treatments have already been administered to COVID-19 patients but have not been systematically evaluated. We performed a systematic literature review to identify all treatments reported to be administered to COVID-19 patients and to assess time to clinically meaningful response for treatments with sufficient data. We searched PubMed, BioRxiv, MedRxiv, and ChinaXiv for articles reporting treatments for COVID-19 patients published between 1 December 2019 and 27 March 2020. Data were analyzed descriptively. Of the 2706 articles identified, 155 studies met the inclusion criteria, comprising 9152 patients. The cohort was 45.4% female and 98.3% hospitalized, and mean (SD) age was 44.4 years (SD 21.0). The most frequently administered drug classes were antivirals, antibiotics, and corticosteroids, and of the 115 reported drugs, the most frequently administered was combination lopinavir/ritonavir, which was associated with a time to clinically meaningful response (complete symptom resolution or hospital discharge) of 11.7 (1.09) days. There were insufficient data to compare across treatments. Many treatments have been administered to the first 9152 reported cases of COVID-19. These data serve as the basis for an open-source registry of all reported treatments given to COVID-19 patients at www.CDCN.org/CORONA . Further work is needed to prioritize drugs for investigation in well-controlled clinical trials and treatment protocols 
611 2 7 |a Journal Article  |2 gnd 
611 2 7 |a Review  |2 gnd 
655 7 |a COVID-19  |2 gnd 
655 7 |a Drug repurposing  |2 gnd 
655 7 |a SARS-CoV-2  |2 gnd 
655 7 |a Systematic literature review  |2 gnd 
689 0 0 |A f  |a Journal Article 
689 0 1 |A f  |a Review 
689 0 |5 DE-601 
689 1 0 |a COVID-19 
689 1 1 |a Drug repurposing 
689 1 2 |a SARS-CoV-2 
689 1 3 |a Systematic literature review 
689 1 |5 DE-601 
700 1 |a Khor, Johnson S 
700 1 |a Gorzewski, Alexander 
700 1 |a Tamakloe, Mark-Avery 
700 1 |a Powers, Victoria 
700 1 |a Kakkis, Joseph J 
700 1 |a Repasky, Mileva 
700 1 |a Taylor, Anne 
700 1 |a Beschloss, Alexander 
700 1 |a Hernandez-Miyares, Laura 
700 1 |a Go, Beatrice 
700 1 |a Nimgaonkar, Vivek 
700 1 |a McCarthy, Madison S 
700 1 |a Kim, Casey J 
700 1 |a Pai, Ruth-Anne Langan 
700 1 |a Frankl, Sarah 
700 1 |a Angelides, Philip 
700 1 |a Jiang, Joanna 
700 1 |a Rasheed, Rozena 
700 1 |a Napier, Erin 
700 1 |a Mackay, Duncan 
700 1 |a Pierson, Sheila K 
773 0 8 |i in  |t Infectious diseases and therapy  |g Vol. 9, No. 3 (2020), p. 435-449  |q 9:3<435-449  |w (DE-601)NLM240422112  |x 2193-8229 
856 4 1 |u http://dx.doi.org/10.1007/s40121-020-00303-8  |3 Volltext 
912 |a GBV_NLM 
951 |a AR 
952 |d 9  |j 2020  |e 3  |b 27  |c 09  |h 435-449